Immunotherapy with Keytruda (Pembolizumab) Doctors Abroad — Page 4

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Associate Professor Abdullah Sakin is the former Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine and currently leads medical oncology at Medipol Bahçelievler Hospital.

• Specialises in internal medicine and medical oncology with a focus on advanced cancer therapies
• Served as Education Officer at the Prof Dr Cemil Taşçıoğlu City Hospital medical oncology clinic
• Contributes to clinical research and the education of future oncology specialists
• Recognised for managing complex cases within Turkish university and training hospital systems

The doctor holds an MD in Radiation Oncology and serves as a consultant. Specializing in advanced cancer treatment techniques, the doctor offers services including Tomotherapy-H, Linear Accelerator, and Brachytherapy. These modalities are utilized to deliver precise radiation therapy, minimizing damage to surrounding healthy tissues and enhancing treatment efficacy.

Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads clinical research as the Managing Director of HCG Manavata Cancer Centre.

• Completed advanced surgical oncology training at the prestigious Tata Memorial Hospital in Mumbai
• Holds a Membership of the Royal College of Surgeons (MRCS) from Edinburgh
• Investigated over 200 clinical trials involving new immunotherapy and targeted treatment protocols
• Serves as a Professor of Surgical Oncology for the National Board of Examinations
• Specialises in managing complex breast and thoracic cancer cases

Dr. Girish Badarkhe is a hematology-oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in leukemia, multiple myeloma, and bone marrow transplants. Dr. Badarkhe treats both adults and children with complex blood disorders. He holds a DM in Clinical Hematology from Medical College, Calcutta.

• Performs allogenic and haploidentical bone marrow transplant procedures.
• Treats blood cancers including lymphoma and acute lymphoblastic leukemia.
• Completed medical training at Grant Medical College and Sir JJ Hospital.
• Works at Maharashtra's first NABH-accredited cancer hospital.

Professor Shaunak Valame is a specialist medical oncologist at HCG Manavata Cancer Centre with expert knowledge in molecular cancer markers and targeted therapies.

• Presented stomach cancer research at the American Society of Clinical Oncology symposium in San Francisco
• Completed oncology training at the prestigious Indraprastha Apollo Hospital in New Delhi
• Lectured at the International Winter School of Oncology programme at AIIMS
• Focuses on the molecular basis of cancer to tailor immunotherapy protocols
• Handled registrar and senior residency roles at major regional cancer research centres

Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.

• Expert in functional rehabilitation for patients recovering from oral cancer.
• Active researcher with multiple publications in various medical journals.
• Works at an NABH-accredited center that treats over 75,000 patients yearly.
• Treats complex conditions including tongue, thyroid, and tonsil cancers.

Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.

• Specializes in minimally invasive procedures, including laparoscopy and thoracoscopy.
• Performs robotic cancer surgeries and advanced endoscopic procedures.
• Served as a former assistant professor at the State Cancer Institute.
• Acts as a co-principal investigator for original clinical research projects.
• Treats complex esophageal, stomach, colon, and rectal cancers.

Dr Shruti Kate is a leading medical oncologist at HCG Manavata Cancer Centre who formerly served as a consultant at the world-renowned Tata Memorial Hospital.

• Specialises in using immunotherapy and metronomic therapy for advanced-stage solid tumours
• Awarded the solo Indian travel grant at the 2018 World Conference on Lung Cancer
• Member of the Immuno-Oncology Society and the American Society of Clinical Oncology
• Expertise covers aggressive lung, breast, and gynae cancers requiring immunotherapy protocols
• Completed prestigious DM training in Medical Oncology at Tata Memorial Hospital

Professor Sridhar P.S. is a senior radiation oncologist at HCG Manavata Cancer Centre who integrates immunotherapy with advanced precision treatments. He holds a Diplomate of the National Board in radiotherapy and focuses on complex oncology cases.

• Member of the Society for Neuro-Oncology involving brain tumour cases
• International experience in combining targeted drug therapy with radiotherapy
• Specialises in managing immunotherapy protocols for solid tumours
• Active member of the Association of Radiation Oncology of India

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.